2018
DOI: 10.1371/journal.pone.0203340
|View full text |Cite
|
Sign up to set email alerts
|

In silico repositioning of approved drugs against Schistosoma mansoni energy metabolism targets

Abstract: Schistosomiasis is a neglected parasitosis caused by Schistosoma spp. Praziquantel is used for the chemoprophylaxis and treatment of this disease. Although this monotherapy is effective, the risk of resistance and its low efficiency against immature worms compromises its effectiveness. Therefore, it is necessary to develop new schistosomicide drugs. However, the development of new drugs is a long and expensive process. The repositioning of approved drugs has been proposed as a quick, cheap, and effective alter… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0
1

Year Published

2020
2020
2022
2022

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 48 publications
0
5
0
1
Order By: Relevance
“…To fast track such investigations, an extensive collection of putative S. mansoni drug candidates is currently available within the TDR Targets database [70]. Alongside this resource, multiple reports have recently described how genome sequencing outputs can be effectively leveraged by both cheminformatics and functional genomics for characterising next-generation schistosome drug targets and chemotherapeutics [66,[71][72][73][74][75][76]. Complementary evidence is provided here to support an essential role for SmNAGAL in the regulation of worm movement and reproductive processes.…”
Section: Discussionmentioning
confidence: 83%
“…To fast track such investigations, an extensive collection of putative S. mansoni drug candidates is currently available within the TDR Targets database [70]. Alongside this resource, multiple reports have recently described how genome sequencing outputs can be effectively leveraged by both cheminformatics and functional genomics for characterising next-generation schistosome drug targets and chemotherapeutics [66,[71][72][73][74][75][76]. Complementary evidence is provided here to support an essential role for SmNAGAL in the regulation of worm movement and reproductive processes.…”
Section: Discussionmentioning
confidence: 83%
“…mansoni drug candidates is currently available within the TDR Targets database [ 84 ]. Alongside this resource, multiple reports have recently described how genome sequencing outputs can be effectively leveraged by both cheminformatics and functional genomics for characterising next-generation schistosome drug targets and chemotherapeutics [ 74 , 85 90 ]. Complementary evidence is provided here to support an essential role for SmNAGAL in the regulation of worm movement and reproductive processes.…”
Section: Discussionmentioning
confidence: 99%
“…Foram encontrados e analisados 44 artigos científicos quanto à epidemiologia da esquistossomose mansônica, publicados em 14 periódicos diferentes. VITORINO et al, 2012;CALIXTO et al, 2018). Apesar de haver pesquisas em outras regiões, como no Nordeste (Piauí, Bahia, Maranhão), as produções dessas outras partes do país ainda são insuficientes, se fazendo necessário o incentivo a pesquisas tanto em áreas endêmicas como em não endêmicas.…”
Section: Epidemiologia Da Esquistossomose Mansoniunclassified